BIOATLA, INC. Revenue Breakdown
No Revenue Breakdown for BCAB on this site yet.
- 2021-12-31: Total revenue $300.00K.
Source checked: the stored Revenue Breakdown page for BCAB.
Revenue by product
Each year (12 month)
| Fiscal year end | Total revenue |
|---|---|
| 2021-12-31 | $300.00K |
Each quarter (3 month)
| Quarter end | Others | Total revenue |
|---|---|---|
| 2023-09-30 | Not split by product $0.00 | $0.00 |
| 2023-06-30 | Not split by product $0.00 | $0.00 |
| 2023-03-31 | Not split by product $0.00 | $0.00 |
| 2022-09-30 | Not split by product $0.00 | $0.00 |
| 2022-06-30 | Not split by product $0.00 | $0.00 |
| 2022-03-31 | Not split by product $0.00 | $0.00 |
| 2021-12-31 | Not split by product $0.00 | $0.00 |
| 2021-09-30 | Not split by product $0.00 | $0.00 |
| 2021-06-30 | Not split by product $300.00K 100.00% | $300.00K |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |